We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
(+22%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
19.13%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$78.4M |
| 2 |
Infosys
INFY
|
+$65M |
| 3 |
F5
FFIV
|
+$64.6M |
| 4 |
Western Digital
WDC
|
+$62.1M |
| 5 |
Cigna
CI
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$69.1M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$68.2M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$57.6M |
| 4 |
Medtronic
MDT
|
+$51.8M |
| 5 |
DRC
DRESSER-RAND GROUP INC
DRC
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.28% |
| 2 | Healthcare | 13.44% |
| 3 | Technology | 12.36% |
| 4 | Financials | 10.47% |
| 5 | Energy | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVDY
376
DELISTED
Everyday Health, Inc.
EVDY
| $1.41M | 0.02% |
110,622
+97,839
| +765% | +$1.24M |
|
377
AppFolio
APPF
$7.04B
| $1.41M | 0.02% |
+100,000
| New | +$1.4M |
|
|
ATYR
378
aTyr Pharma
ATYR
$50.1M
| $1.39M | 0.02% |
+5,366
| New | +$1.67M |
|
379
Wingstop
WING
$3.18B
| $1.39M | 0.02% |
+48,896
| New | +$1.41M |
|
380
Fate Therapeutics
FATE
$326M
| $1.38M | 0.02% |
213,167
+130,604
| +158% | +$781K |
|
|
JOY
381
DELISTED
Joy Global Inc
JOY
| $1.37M | 0.02% |
+37,733
| New | +$1.52M |
|
382
Evolent Health
EVH
$447M
| $1.36M | 0.02% |
+70,000
| New | +$1.3M |
|
383
QuinStreet
QNST
$1.21B
| $1.36M | 0.02% |
211,262
+3,422
| +2% | +$20.1K |
|
384
Acacia Research
ACTG
$470M
| $1.32M | 0.01% |
+150,000
| New | +$1.54M |
|
385
Amdocs
DOX
$6.22B
| $1.31M | 0.01% |
23,935
-414,820
| -95% | -$22.8M |
|
|
MHFI
386
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $1.29M | 0.01% |
12,891
-285,262
| -96% | -$29.8M |
|
|
CYTO
387
DELISTED
Altamira Therapeutics Ltd
CYTO
| $1.29M | 0.01% |
3
+2
| +200% | +$829K |
|
|
ATRS
388
DELISTED
Antares Pharma, Inc.
ATRS
| $1.28M | 0.01% |
+616,290
| New | +$1.49M |
|
389
CME Group
CME
$94.8B
| $1.28M | 0.01% |
+13,770
| New | +$1.28M |
|
390
Seres Therapeutics
MCRB
$48.4M
| $1.25M | 0.01% |
+1,500
| New | +$1.31M |
|
|
PBPB
391
DELISTED
Potbelly
PBPB
| $1.24M | 0.01% |
101,024
-145,365
| -59% | -$2.04M |
|
392
Nasdaq
NDAQ
$52.9B
| $1.23M | 0.01% |
75,672
-20,385
| -21% | -$342K |
|
393
Dare Bioscience
DARE
$21M
| $1.21M | 0.01% |
+2,194
| New | +$1.51M |
|
|
EVFM
394
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.17M | 0.01% |
1,445
+304
| +27% | +$195K |
|
|
HTGM
395
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.16M | 0.01% |
+576
| New | +$1.47M |
|
396
H&R Block
HRB
$5.86B
| $1.16M | 0.01% |
38,970
-949,943
| -96% | -$29.8M |
|
|
CASC
397
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.12M | 0.01% |
50,021
-74,979
| -60% | -$1.19M |
|
398
Eagle Bancorp
EGBN
$845M
| $1.1M | 0.01% |
25,121
-24,879
| -50% | -$991K |
|
399
OneMain Financial
OMF
$7.47B
| $1.08M | 0.01% |
+23,472
| New | +$1.14M |
|
400
Ascendis Pharma A/S
ASND
$16.8B
| $1.08M | 0.01% |
60,940
-39,015
| -39% | -$683K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2015 Portfolio in Review
As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.
- Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
- Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
- Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
- Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
- Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
- Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.
Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.